Forecasting the Incidence of Testis Cancer in Europe From 2012-2035

Isfahan University of Medical Sciences

Science Communicator Platform

Share By

Forecasting the Incidence of Testis Cancer in Europe From 2012-2035

Valipour AA¹ ; Mohammadian M² ; Mohammadianhafshejani A^{3, 4} ; Islamie Farsani S⁵

Source: Iranian Journal of Public Health Published:2017

Abstract

[No abstract available]

Style	Citing Format
MLA	Valipour AA, et al.. "Forecasting the Incidence of Testis Cancer in Europe From 2012-2035." Iranian Journal of Public Health, vol. 46, no. 10, 2017, pp. 1448-1449.
APA	Valipour AA, Mohammadian M, Mohammadianhafshejani A, Islamie Farsani S (2017). Forecasting the Incidence of Testis Cancer in Europe From 2012-2035. Iranian Journal of Public Health, 46(10), 1448-1449.
Chicago	Valipour AA, Mohammadian M, Mohammadianhafshejani A, Islamie Farsani S. "Forecasting the Incidence of Testis Cancer in Europe From 2012-2035." Iranian Journal of Public Health 46, no. 10 (2017): 1448-1449.
Harvard	Valipour AA et al. (2017) 'Forecasting the Incidence of Testis Cancer in Europe From 2012-2035', Iranian Journal of Public Health, 46(10), pp. 1448-1449.
Vancouver	Valipour AA, Mohammadian M, Mohammadianhafshejani A, Islamie Farsani S. Forecasting the Incidence of Testis Cancer in Europe From 2012-2035. Iranian Journal of Public Health. 2017;46(10):1448-1449.
BibTex	@article{ author = {Valipour AA and Mohammadian M and Mohammadianhafshejani A and Islamie Farsani S}, title = {Forecasting the Incidence of Testis Cancer in Europe From 2012-2035}, journal = {Iranian Journal of Public Health}, volume = {46}, number = {10}, pages = {1448-1449}, year = {2017} }
RIS	TY - JOUR AU - Valipour AA AU - Mohammadian M AU - Mohammadianhafshejani A AU - Islamie Farsani S TI - Forecasting the Incidence of Testis Cancer in Europe From 2012-2035 JO - Iranian Journal of Public Health VL - 46 IS - 10 SP - 1448 EP - 1449 PY - 2017 ER -